Precision medicine in lung cancer: the battle continues
- PMID: 28066565
- PMCID: PMC5179408
- DOI: 10.21037/jtd.2016.11.46
Precision medicine in lung cancer: the battle continues
Conflict of interest statement
D Morgensztern: Advisory Board Bristol-Myers Squibb. The other author has no conflicts of interest to declare.
Comment on
-
The BATTLE-2 Study: A Biomarker-Integrated Targeted Therapy Study in Previously Treated Patients With Advanced Non-Small-Cell Lung Cancer.J Clin Oncol. 2016 Oct 20;34(30):3638-3647. doi: 10.1200/JCO.2015.66.0084. J Clin Oncol. 2016. PMID: 27480147 Free PMC article.
References
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources